nodes	percent_of_prediction	percent_of_DWPC	metapath
Alprostadil—ABCC5—ABC-family proteins mediated transport—ABCA4—cleft lip	0.0852	0.0852	CbGpPWpGaD
Alprostadil—ABCC4—ABC-family proteins mediated transport—ABCA4—cleft lip	0.059	0.059	CbGpPWpGaD
Alprostadil—ABCC4—Ectoderm Differentiation—MAFB—cleft lip	0.0413	0.0413	CbGpPWpGaD
Alprostadil—ABCC5—NRF2 pathway—EPHA3—cleft lip	0.0327	0.0327	CbGpPWpGaD
Alprostadil—ABCC5—Fluoropyrimidine Activity—TYMS—cleft lip	0.0294	0.0294	CbGpPWpGaD
Alprostadil—ABCC4—Platelet degranulation—TGFB3—cleft lip	0.0293	0.0293	CbGpPWpGaD
Alprostadil—ABCC4—Response to elevated platelet cytosolic Ca2+—TGFB3—cleft lip	0.0279	0.0279	CbGpPWpGaD
Alprostadil—ABCC5—Fluoropyrimidine Activity—MTHFR—cleft lip	0.0257	0.0257	CbGpPWpGaD
Alprostadil—ABCC4—Ectoderm Differentiation—TFAP2A—cleft lip	0.0237	0.0237	CbGpPWpGaD
Alprostadil—ABCC4—NRF2 pathway—EPHA3—cleft lip	0.0226	0.0226	CbGpPWpGaD
Alprostadil—PTGER2—GPCR ligand binding—WNT9B—cleft lip	0.0222	0.0222	CbGpPWpGaD
Alprostadil—PTGIR—Endothelin Pathways—NOS3—cleft lip	0.0208	0.0208	CbGpPWpGaD
Alprostadil—ABCC4—Fluoropyrimidine Activity—TYMS—cleft lip	0.0204	0.0204	CbGpPWpGaD
Alprostadil—ABCC4—Fluoropyrimidine Activity—MTHFR—cleft lip	0.0178	0.0178	CbGpPWpGaD
Alprostadil—PTGER2—GPCR ligand binding—WNT3—cleft lip	0.0176	0.0176	CbGpPWpGaD
Alprostadil—SLCO2A1—Transmembrane transport of small molecules—ABCA4—cleft lip	0.0169	0.0169	CbGpPWpGaD
Alprostadil—SLCO3A1—Transmembrane transport of small molecules—ABCA4—cleft lip	0.0161	0.0161	CbGpPWpGaD
Alprostadil—ABCC5—NRF2 pathway—TGFA—cleft lip	0.0152	0.0152	CbGpPWpGaD
Alprostadil—PTGIR—GPCR ligand binding—WNT9B—cleft lip	0.015	0.015	CbGpPWpGaD
Alprostadil—PTGER1—GPCR ligand binding—WNT9B—cleft lip	0.015	0.015	CbGpPWpGaD
Alprostadil—PTGIR—Thromboxane A2 receptor signaling—NOS3—cleft lip	0.0136	0.0136	CbGpPWpGaD
Alprostadil—ABCC4—Platelet activation, signaling and aggregation—TGFB3—cleft lip	0.013	0.013	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—ARHGAP29—cleft lip	0.0123	0.0123	CbGpPWpGaD
Alprostadil—PTGER1—GPCR ligand binding—WNT3—cleft lip	0.0119	0.0119	CbGpPWpGaD
Alprostadil—PTGIR—GPCR ligand binding—WNT3—cleft lip	0.0119	0.0119	CbGpPWpGaD
Alprostadil—ABCC4—Ectoderm Differentiation—SPRY2—cleft lip	0.0119	0.0119	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—WNT9B—cleft lip	0.0114	0.0114	CbGpPWpGaD
Alprostadil—PTGIR—Hemostasis—TGFB3—cleft lip	0.0112	0.0112	CbGpPWpGaD
Alprostadil—ABCC4—Ectoderm Differentiation—BMP4—cleft lip	0.0106	0.0106	CbGpPWpGaD
Alprostadil—ABCC4—NRF2 pathway—TGFA—cleft lip	0.0106	0.0106	CbGpPWpGaD
Alprostadil—PTGIR—Platelet homeostasis—NOS3—cleft lip	0.0105	0.0105	CbGpPWpGaD
Alprostadil—PTGER2—GPCR ligand binding—PTCH1—cleft lip	0.00966	0.00966	CbGpPWpGaD
Alprostadil—SLCO2B1—Transmembrane transport of small molecules—ABCA4—cleft lip	0.00931	0.00931	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—WNT3—cleft lip	0.00905	0.00905	CbGpPWpGaD
Alprostadil—ABCC5—Transmembrane transport of small molecules—ABCA4—cleft lip	0.0089	0.0089	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—ARHGAP29—cleft lip	0.0083	0.0083	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—ARHGAP29—cleft lip	0.0083	0.0083	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—WNT9B—cleft lip	0.0077	0.0077	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—WNT9B—cleft lip	0.0077	0.0077	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—WNT9B—cleft lip	0.00673	0.00673	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—TGFB3—cleft lip	0.0067	0.0067	CbGpPWpGaD
Alprostadil—PTGIR—GPCR ligand binding—PTCH1—cleft lip	0.00653	0.00653	CbGpPWpGaD
Alprostadil—PTGER1—GPCR ligand binding—PTCH1—cleft lip	0.00653	0.00653	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—NOG—cleft lip	0.00645	0.00645	CbGpPWpGaD
Alprostadil—ABCC4—Transmembrane transport of small molecules—ABCA4—cleft lip	0.00617	0.00617	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—WNT3—cleft lip	0.00611	0.00611	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—WNT3—cleft lip	0.00611	0.00611	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—ABCA4—cleft lip	0.006	0.006	CbGpPWpGaD
Alprostadil—ABCC4—Ectoderm Differentiation—FGFR2—cleft lip	0.00589	0.00589	CbGpPWpGaD
Alprostadil—ABCC5—Disease—WNT9B—cleft lip	0.00558	0.00558	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—WNT3—cleft lip	0.00535	0.00535	CbGpPWpGaD
Alprostadil—ABCC5—Disease—ABCA4—cleft lip	0.00498	0.00498	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—PTCH1—cleft lip	0.00496	0.00496	CbGpPWpGaD
Alprostadil—ABCC5—Disease—SLC19A1—cleft lip	0.00455	0.00455	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—WNT9B—cleft lip	0.00455	0.00455	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—WNT9B—cleft lip	0.00455	0.00455	CbGpPWpGaD
Alprostadil—ABCC5—Disease—WNT3—cleft lip	0.00444	0.00444	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—NOG—cleft lip	0.00436	0.00436	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—NOG—cleft lip	0.00436	0.00436	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—ABCA4—cleft lip	0.00405	0.00405	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—ABCA4—cleft lip	0.00405	0.00405	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—SLC19A1—cleft lip	0.00381	0.00381	CbGpPWpGaD
Alprostadil—ABCC5—Disease—TCN2—cleft lip	0.00377	0.00377	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—WNT3—cleft lip	0.00361	0.00361	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—WNT3—cleft lip	0.00361	0.00361	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—SPRY2—cleft lip	0.00354	0.00354	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—FGF7—cleft lip	0.00354	0.00354	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—PTCH1—cleft lip	0.00335	0.00335	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—PTCH1—cleft lip	0.00335	0.00335	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—FGF8—cleft lip	0.00326	0.00326	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—TCN2—cleft lip	0.00316	0.00316	CbGpPWpGaD
Alprostadil—ABCC5—Disease—FGF7—cleft lip	0.00293	0.00293	CbGpPWpGaD
Alprostadil—ABCC5—Disease—SPRY2—cleft lip	0.00293	0.00293	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—PTCH1—cleft lip	0.00293	0.00293	CbGpPWpGaD
Alprostadil—ABCC5—Disease—FGF8—cleft lip	0.00271	0.00271	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—FGF3—cleft lip	0.00266	0.00266	CbGpPWpGaD
Alprostadil—ABCC4—Ectoderm Differentiation—MYC—cleft lip	0.00262	0.00262	CbGpPWpGaD
Alprostadil—ABCC5—Disease—MTR—cleft lip	0.00261	0.00261	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—FGF9—cleft lip	0.00259	0.00259	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—FGF7—cleft lip	0.00239	0.00239	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—FGF7—cleft lip	0.00239	0.00239	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—SPRY2—cleft lip	0.00239	0.00239	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—SPRY2—cleft lip	0.00239	0.00239	CbGpPWpGaD
Alprostadil—PTGIR—Hemostasis—NOS3—cleft lip	0.00234	0.00234	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—FGF8—cleft lip	0.0022	0.0022	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—FGF8—cleft lip	0.0022	0.0022	CbGpPWpGaD
Alprostadil—ABCC5—Disease—FGF3—cleft lip	0.0022	0.0022	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—MTR—cleft lip	0.00219	0.00219	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—FGF10—cleft lip	0.00218	0.00218	CbGpPWpGaD
Alprostadil—ABCC5—Disease—FGF9—cleft lip	0.00215	0.00215	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—PTCH1—cleft lip	0.00198	0.00198	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—PTCH1—cleft lip	0.00198	0.00198	CbGpPWpGaD
Alprostadil—ABCC5—Disease—FGF10—cleft lip	0.00181	0.00181	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—FGF3—cleft lip	0.00179	0.00179	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—FGF3—cleft lip	0.00179	0.00179	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—FGFR2—cleft lip	0.00175	0.00175	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—FGF9—cleft lip	0.00175	0.00175	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—FGF9—cleft lip	0.00175	0.00175	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—FGFR1—cleft lip	0.00163	0.00163	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—FGFR3—cleft lip	0.00154	0.00154	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—FGF10—cleft lip	0.00148	0.00148	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—FGF10—cleft lip	0.00148	0.00148	CbGpPWpGaD
Alprostadil—ABCC5—Disease—FGFR2—cleft lip	0.00145	0.00145	CbGpPWpGaD
Alprostadil—ABCC5—Disease—MTHFR—cleft lip	0.0014	0.0014	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—NOS3—cleft lip	0.0014	0.0014	CbGpPWpGaD
Alprostadil—ABCC5—Disease—FGFR1—cleft lip	0.00136	0.00136	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—TYMS—cleft lip	0.00134	0.00134	CbGpPWpGaD
Alprostadil—ABCC5—Disease—FGFR3—cleft lip	0.00128	0.00128	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—FGF2—cleft lip	0.00119	0.00119	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—FGFR2—cleft lip	0.00118	0.00118	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—FGFR2—cleft lip	0.00118	0.00118	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—NOS3—cleft lip	0.00118	0.00118	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—MTHFR—cleft lip	0.00117	0.00117	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—FGFR1—cleft lip	0.0011	0.0011	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—FGFR1—cleft lip	0.0011	0.0011	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—FGFR3—cleft lip	0.00104	0.00104	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—FGFR3—cleft lip	0.00104	0.00104	CbGpPWpGaD
Alprostadil—ABCC5—Disease—FGF2—cleft lip	0.00099	0.00099	CbGpPWpGaD
Alprostadil—ABCC5—Disease—NOS3—cleft lip	0.000976	0.000976	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—NOS3—cleft lip	0.000818	0.000818	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—FGF2—cleft lip	0.000806	0.000806	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—FGF2—cleft lip	0.000806	0.000806	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—NOS3—cleft lip	0.000795	0.000795	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—NOS3—cleft lip	0.000795	0.000795	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—MYC—cleft lip	0.00078	0.00078	CbGpPWpGaD
Alprostadil—ABCC5—Disease—MYC—cleft lip	0.000647	0.000647	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—MYC—cleft lip	0.000527	0.000527	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—MYC—cleft lip	0.000527	0.000527	CbGpPWpGaD
